1. Home
  2. TENX vs CPSH Comparison

TENX vs CPSH Comparison

Compare TENX & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • CPSH
  • Stock Information
  • Founded
  • TENX 1967
  • CPSH 1984
  • Country
  • TENX United States
  • CPSH United States
  • Employees
  • TENX N/A
  • CPSH N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • CPSH Building Materials
  • Sector
  • TENX Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • TENX Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • TENX 21.8M
  • CPSH 23.4M
  • IPO Year
  • TENX N/A
  • CPSH 1987
  • Fundamental
  • Price
  • TENX $6.37
  • CPSH $1.81
  • Analyst Decision
  • TENX Strong Buy
  • CPSH
  • Analyst Count
  • TENX 4
  • CPSH 0
  • Target Price
  • TENX $20.67
  • CPSH N/A
  • AVG Volume (30 Days)
  • TENX 38.7K
  • CPSH 52.4K
  • Earning Date
  • TENX 11-13-2024
  • CPSH 03-05-2025
  • Dividend Yield
  • TENX N/A
  • CPSH N/A
  • EPS Growth
  • TENX N/A
  • CPSH N/A
  • EPS
  • TENX N/A
  • CPSH N/A
  • Revenue
  • TENX N/A
  • CPSH $21,937,262.00
  • Revenue This Year
  • TENX N/A
  • CPSH N/A
  • Revenue Next Year
  • TENX N/A
  • CPSH N/A
  • P/E Ratio
  • TENX N/A
  • CPSH N/A
  • Revenue Growth
  • TENX N/A
  • CPSH N/A
  • 52 Week Low
  • TENX $2.77
  • CPSH $1.27
  • 52 Week High
  • TENX $21.46
  • CPSH $2.59
  • Technical
  • Relative Strength Index (RSI)
  • TENX 57.59
  • CPSH 63.43
  • Support Level
  • TENX $5.92
  • CPSH $1.62
  • Resistance Level
  • TENX $6.65
  • CPSH $1.77
  • Average True Range (ATR)
  • TENX 0.43
  • CPSH 0.11
  • MACD
  • TENX -0.02
  • CPSH 0.01
  • Stochastic Oscillator
  • TENX 56.21
  • CPSH 71.43

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: